Companies developing artificial intelligence and machine learning technologies, businesses deploying them at scale, and investors funding both turn to us for counsel on the regulatory, transactional, and litigation matters that arise across the AI lifecycle.

Our clients span technology, life sciences and healthcare, energy, financial services, real estate, manufacturing, and logistics — from major corporations to emerging growth companies, and the strategic acquirers and private equity sponsors backing them.

We advise on:

• Regulatory. FDA regulation of AI-enabled medical devices, including predetermined change control plans for adaptive AI/ML systems, and AI in drug development; the EU AI Act, UK AI regulation, evolving US state AI laws, and federal preemption developments; generative AI and intellectual property; AI in employment, content moderation, and advertising; AI governance and ethics frameworks; data protection impact assessments and cross-border privacy compliance.
• Transactions. Mergers, acquisitions, and investments in AI-enabled platforms; data center transactions, energy procurement, and infrastructure financings supporting AI buildouts; commercial agreements covering AI development, licensing, and deployment; training data and dataset licensing.
• Disputes and enforcement. AI-related litigation, including contractual, product liability, IP, and tort claims; government investigations and regulatory enforcement; e-discovery involving generative AI; trade secret protection in AI development.

Our team includes engineers and attorneys with technical certifications, former senior in-house counsel from leading technology companies, and lawyers active in industry bodies shaping AI policy. Our work covers generative AI, large language models, agentic AI, and machine learning, all as applied to conversational AI, fraud detection and digital identity, digital health and personalized medicine, e-commerce and marketplace platforms, facial and biometric recognition, robotics, and autonomous vehicles.